TGFB1 and aortic aneurysm: Several studies have reported a direct association between elevated TGFβ signalling and MFS pathology in mouse models, where injection of a TGFβ-neutralising antibody restored alveolarisation and atrioventricular valve integrity and prevented aortic aneurysms, the most severe clinical feature of MFS [[132], [133], [134]].